Newly Joined Talent
Ms. Yue He will join Clin-nov Medical as the Director of Human Resources Operation on Monday, May 26th, 2022, reporting to the Deputy General Manager Ms. Xiaoxiao Gu.
In this role, Ms. Yue He will be responsible for improving and optimizing the management and operation system of the Dept. of Human Resources and Administration in Clin-nov Medical. Ms. He will develop and implement HR policies and operation processes as well as the improvement of the Talent & Learning Development system.
Graduated from Beihang University as a master’s degree in Business Administration, Ms. Yue He has 17 years of work experience in human resource management. She has served Fortune 500 companies and start-ups, and thus experienced different stages of enterprise development. During her previous career, Ms. He successfully addressed complex situations by continuously optimizing the company’s strategic goals to achieve the required human resources plan strategies. Ensuring balance between resource input and output and keeping focus on talents and their development. She was responsible for the budget on human resources, recruitment, corporate culture, performance, salary, and bonus assessment and distribution, therefore accumulating extensive experience in the management of human resources and team management.
Dr. Lin Zhang officially joined AsymBio as Senior Director of PM on May 16th, 2022, reporting to AsymBio CTO Mr. Kai Gao.
Dr. Lin Zhang will be responsible for the overall project management (PM) of AsymBio, supporting the whole project life cycle, tracking project quotation, start-up, execution and closure. At the same time, be responsible for promoting AsymBio biomacromolecule and ADC one-stop service projects, coordinating the connection and communication with other business units of the corporate. With the development of the overall business, he will also be responsible for optimizing the project management process to reserve capabilities for the rapid growth of AsymBio business. Dr. Lin Zhang, accomplished his doctor’s degree of Genetics at Fudan University in 2008. He had been with Abcam (China), WuXi Biologics, and Lyvgen Biopharma as Director of Project Management. He has 10 years working experience in the pharmaceutical industry, with sophisticated understanding in biological drug development process. He has demonstrated capability in leading multiple IND-enabling projects to approval and FIH clinical study.